Spyre Therapeutics, Inc. (SYRE)
85.70
-1.38
(-1.59%)
USD |
NASDAQ |
Sep 25, 16:00
85.70
0.00 (0.00%)
After-Hours: 16:21
Spyre Therapeutics Cash and Short Term Investments (Quarterly) : 1.145B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.145B |
| March 31, 2026 | 741.47M |
| December 31, 2025 | 756.53M |
| September 30, 2025 | 486.20M |
| June 30, 2025 | 526.58M |
| March 31, 2025 | 564.82M |
| December 31, 2024 | 603.09M |
| September 30, 2024 | 414.23M |
| June 30, 2024 | 426.00M |
| March 31, 2024 | 484.64M |
| December 31, 2023 | 339.28M |
| September 30, 2023 | 203.60M |
| June 30, 2023 | 235.36M |
| March 31, 2023 | 38.48M |
| December 31, 2022 | 55.71M |
| September 30, 2022 | 73.68M |
| June 30, 2022 | 88.55M |
| March 31, 2022 | 66.72M |
| December 31, 2021 | 93.13M |
| September 30, 2021 | 112.43M |
| June 30, 2021 | 128.58M |
| March 31, 2021 | 126.66M |
| December 31, 2020 | 146.27M |
| September 30, 2020 | 139.98M |
| Date | Value |
|---|---|
| June 30, 2020 | 157.73M |
| March 31, 2020 | 48.99M |
| December 31, 2019 | 71.95M |
| September 30, 2019 | 88.70M |
| June 30, 2019 | 105.54M |
| March 31, 2019 | 123.72M |
| December 31, 2018 | 74.51M |
| September 30, 2018 | 64.74M |
| June 30, 2018 | 72.19M |
| March 31, 2018 | 43.48M |
| December 31, 2017 | 50.30M |
| September 30, 2017 | 55.75M |
| June 30, 2017 | 63.39M |
| March 31, 2017 | 57.87M |
| December 31, 2016 | 63.50M |
| September 30, 2016 | 68.04M |
| June 30, 2016 | 73.73M |
| March 31, 2016 | 29.07M |
| December 31, 2015 | 33.14M |
| September 30, 2015 | 34.22M |
| June 30, 2015 | 39.13M |
| March 31, 2015 | 43.84M |
| December 31, 2014 | 2.656M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AbbVie, Inc. | 6.569B |
| Incyte Corp. | 4.536B |
| SELLAS Life Sciences Group, Inc. | 138.44M |
| BridgeBio Pharma, Inc. | 720.71M |
| Relay Therapeutics, Inc. | 910.93M |